secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227692
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen secures $1.5B term loan to fund Reata acquisition; bridge loan canceled
------------------------------------------------------------------------------

- $1.5B unsecured term loan facility split into $750M 364-day Tranche A and $750M 3-year Tranche B.
- Proceeds to pay part of Reata buyout, repay existing Reata debt, and cover transaction fees.
- Interest rates: Term SOFR + 1.250%-1.625% or Base Rate + 0.250%-0.625%, based on debt ratings.
- Financial covenant of 3.5x max leverage, temporarily rising to 4.0x upon merger close.
- Prior $1.5B 364-day bridge loan commitment from JPMorgan terminated and canceled.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312523227692/0001193125-23-227692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312523227692/d540978d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer